References: Benigni
Last Updated: November 29, 2011	Print | Email

Alcaraz, J., Xu, R., Mori, H., Nelson, C.M., Mroue, R., Spencer, V.A., et al. (2008). Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 27, 2829-2838.

Allen, B.C., Crump, K.S. & Shipp, A.M. (1988). Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 8, 531-544.

Ashby, J. (1985). Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environ. Mutagen. 7, 919-921.

Baker, S.G., Cappuccio, A. & Potter, J.D. (2010). Research on early-stage carcinogenesis: Are we approaching paradigm instability? J. Clin. Oncol. 28, 3215-3218.

Barrett, J.C. & Ts'o, P.O. (1978). Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl. Acad. Sci. U.S.A. 75, 3761-3765.

Benigni, R. & Bossa, C. (2011a). Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitromutagenicity and cell transformation assays. Mutagenesis. 26, 455-460.

Benigni, R. & Bossa, C. (2011b). Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chem. Revs. 111, 2507-2536.

Benigni, R., Bossa, C., Giuliani, A. & Tcheremenskaia, O. (2010a). Exploring In Vitro/In Vivo Correlations: Lessons Learned from Analyzing Phase I Results of U.S.EPA's ToxCast Project. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Revs. 28, 272-286.

Benigni, R., Bossa, C., Tcheremenskaia, O., Battistelli, C.L. & Crettaz, P. (2011). The New ISSMIC Database on In Vivo Micronucleus, and Its Role in Assessing Genotoxicity Testing Strategies. Mutagenesis. Sept 30, Epub ahead of print.

Benigni, R., Bossa, C., Tcheremenskaia, O. & Giuliani, A. (2010b). Alternatives to the carcinogenicity bioassay: In silico methods, and the in vitro and in vivo mutagenicity assays. Exp. Opin. Drug Metab. Toxicol. 6, 1-11.

Benigni, R., Netzeva, T.I., Benfenati, E., Bossa, C., Franke, R., Helma,C., et al. (2007). The Expanding role of predictive toxicology: An update on the (Q)SAR models for mutagens and carcinogens. J. Environ. Sci. Health. C. Environ. Carcinog. Ecotoxicol. Revs. 25, 53-97.

Berwald, Y. & Sachs, L. (1963). In vitro cell transformation with chemical carcinogens. Nature. 200, 1182-1184.

Berwald, Y. & Sachs, L. (1965). In Vitro Transformation of Normal Cells to Tumour Cells by Carcinogenic Hydrocarbons. J. Natl. Canc. Inst. 35, 641-661.

Bignami, M., Ficorella, C., Dogliotti, E., Norman, R.L., Kaighn, M.E. & Saffiotti, U. (1984). Temporal dissociation in the exposure times required for maximal induction of cytotoxicity, mutation, and transformation by N-methyl-N'-nitro-N-nitrosoguanidine in the BALB/3T3 ClA31-1-1 cell line. Cancer Res. 44, 2452-2457.

Bucher, J.R. (2000). Doses in rodent cancer studies: Sorting fact from fiction. Drug Metab. Rev. 32, 153-163.

Corvi, R., Albertini, S., Hartung, T., Hoffmann, S., Maurici, D., Pfuhler, S., et al. (2008). ECVAM retrospective evaluation of in vitromicronucleus test (MNT). Mutagenesis. 23, 271-283.

Fung, V.A., Huff, J., Weisburger, E.K. & Hoel, D.G. (1993). Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: Scientific and public health impact. Fund. Appl. Toxicol. 20, 413-436.

Goodman, G. & Wilson, R. (1991). Quantitative prediction of human cancer risk from rodent carcinogenic potencies: A closer look at the epidemiological evidence for some chemicals not definitively carcinogenic in humans. Regulat. Pharmacol. Toxicol. 14, 118-146.

Haber, D.A. & Settleman, J. (2007). Cancer: Drivers and passengers. Nature. 446, 145-146.

Hansch, C., Kim, D., Leo, A.J., Novellino,E ., Silipo, C. & Vittoria, A. (1989). Toward a quantitative comparative toxicology of organic compounds. Crit. Rev. Toxicol. 19, 185-226.

Haseman, J.K., Melnick, R.L., Tomatis, L. & Huff, J. (2001). Carcinogenesis bioassays: Study duration and biological relevance. Food Chem. Toxicol. 39, 739-744.

Hernandez, L.G., van Steeg, H., Luijten, M. & van Benthem, J. (2009). Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. Mutat. Res. 682, 94-109.

Huff, J. (1999a). Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties. Ann. N.Y. Acad. Sci. 895, 56-79.

Huff, J. (1999b). Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans. In: Carcinogenicity. Testing, Predicting, and Interpreting Chemical Effects. (Ed. by K.T.Kitchin), pp. 21-123. New York, Marcel Dekker, Inc.

Huff, J.E., Haseman, J.K. & Rall, D.P. (1991). Scientific concepts, value, and significance of chemical carcinogenesis studies. Ann. Rev. Pharmacol. Toxicol. 31, 621-625.

Kalluri, R. & Zeisberg, M. (2006). Fibroblasts in cancer. Nat. Rev. Cancer. 6, 392-401.

Kirkland, D., Kasper, P., Muller, L., Corvi, R. & Speit, G. (2008). Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop. Mutat. Res. 653, 99-108.

Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., et al. (2007). How to reduce false positive results when undertaking in vitrogenotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutat. Res. 628, 31-55.

Kirkland, D. & Speit, G. (2008). Evaluation of the ability of a battery of three in vitrogenotoxicity tests to discriminate rodent carcinogens and non-carcinogens III. Appropriate follow-up testing in vivo. Mutat. Res. 654, 114-132.

OECD. Detailed review paper on cell transformation assays for detection of chemical carcinogens. [31]. (2007). Paris, OECD. OECD Series on Testing and Assessment.

Pedersen, F., de Brujin, J., Munn, S.J. & Van Leeuwen, K. Assessment of additional testing needs under REACH. Effects of (Q)SARs, risk based testing and voluntary industry initiatives. JRC report EUR 20863 EN. (2003). Ispra, EUR.

Potter, J.D. (2007). Morphostats, morphogens, microarchitecture and malignancy. Nat. Rev. Cancer. 7, 464-474.

Soto, A.M. & Sonnenschein, C. (2011). The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory. Bioassays. 33, 332-340.

Tomatis, L., Huff, J., Hertz-Picciotto, I., Sandler, D.P., Bucher, J., Boffetta, P., et al. (1997). Avoided and avoidable risks of cancer. Carcinogenesis. 18, 97-105.

Tomatis, L., Melnick, R.L., Haseman, J.K., Barrett, J.C. & Huff, J. (2001). Alleged "misconceptions" distort perceptions of environmental cancer risks. FASEB J. 15, 195-203.

Van der Jagt, K., Munn, S.J., Torslov, J. & de Brujin, J. Alternative approaches can reduce the use of test animals under REACH. Addendum to the Report "Assessment of addtional testing needs under REACH. Effects of (Q)SARs, risk based testing and voluntary industry initiatives". JRC Report EUR 21405 EN. (2004). Ispra, European Commission Joint Research Centre.

Van Leeuwen, K., Schultz, T.W., Henry, T., Diderich, B. & Veith, G.D. (2009). Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ. Res. 20, 207-220.

Whiteside, T.L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene. 27, 5904-5912.

Worth, A.P. (2010). The role of QSAR methodology in the regulatory assessment of chemicals. In: Recent Advances in QSAR Studies: Methods and Applications. (Ed. by T.Puzyn, J.Leszczynski & M.T.D.Cronin), pp. 367-382. Heidelberg, Springer.

Worth, A.P., Bassan, A., de Brujin, J., Gallegos Saliner, A., Netzeva, T.I., Pavan, M., et al. (2007). The Role of the European Chemicals Bureau in Promoting the Regulatory Use of (Q)SAR Methods. SAR QSAR Environ. Res. 18, 111-125.

Wunderlich, V. (2007). Early references to the mutational origin of cancer. Int. J. Epidemiol. 36, 246-247.

Zeiger, E. (1998). Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance. Regulat. Pharmacol. Toxicol. 28, 85-95.

Zeiger, E. (2004). History and rationale of genetic toxicity testing: An impersonal, and sometimes personal, view. Environ. Health Perspect. 44, 363-371.